GT Biopharma, Inc. (GTBP) has 3 open-market insider trades by 3 insiders since 2020. The most active filer is Bruce Wendel, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Bruce Wendel | Dir | — | 1 | $26K | 2021-02-16 |
| Michael Martin Breen | Chairman | — | 1 | $25K | 2023-08-11 |
| Manu Ohri | Secretary | — | 1 | $25K | 2023-08-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael Martin Breen | Chairman | Buy | $25K | 2023-04-11 |
| Manu Ohri | Secretary | Buy | $25K | 2023-04-06 |
| Steven W. Weldon | — | Sell | $63K | 2020-12-21 |
| Steven W. Weldon | — | Sell | $61K | 2020-12-16 |
| Steven W. Weldon | — | Sell | $98K | 2020-12-11 |
| Bruce Wendel | Director | Buy | $26K | 2020-11-16 |
Companies that share insiders with GTBP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.